Related Experiment Video
Updated: Jul 15, 2026

10:46
Preparation and Photoacoustic Analysis of Cellular Vehicles Containing Gold Nanorods
Published on: May 2, 2016
6.9K
Light-Responsive Layer-By-Layer Film Containing Gold Nanorods for Sequential Drug Release.
Baljinder Singh1, Mamta Ramgopal Chejara1, Myoung-Hwan Park1,2,3,4
1Department of Convergence Science, Sahmyook University, Seoul 01795, South Korea.
ACS Omega
|December 25, 2023
Summary
This study developed stable layer-by-layer films for sequential drug delivery. These films release camptothecin and doxorubicin on demand, showing promise for treating complex conditions like skin cancer.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Multidrug-loaded layer-by-layer (LbL) films offer controlled sequential drug release.
- Synergistic drug effects can improve therapeutic efficacy for complex diseases like skin cancer.
Purpose of the Study:
- To develop stable LbL films for sequential and on-demand release of camptothecin (CPT) and doxorubicin (DOX).
- To investigate the stimuli-responsive drug release mechanisms.
- To evaluate the potential of this platform for cancer therapy.
Main Methods:
- Fabrication of LbL films using polyethylenimine, CPT-loaded gold nanorods (GNRs), poly(styrenesulfonate), and DOX via electrostatic interactions.
- Characterization of drug loading, stability, and release kinetics.
- Evaluation of pH-dependent DOX release and near-infrared (NIR) triggered CPT release from GNRs.
Main Results:
- LbL films successfully co-loaded CPT and DOX, with tunable drug content.
- CPT-loaded GNRs exhibited stability and NIR absorption.
- pH-dependent DOX release and NIR-triggered CPT release were achieved.
- The films demonstrated cytocompatibility and anticancer effects.
Conclusions:
- The developed LbL films provide an effective platform for sequential and stimuli-responsive drug delivery.
- This approach holds significant potential for enhancing cancer treatment through synergistic and on-demand drug release.
- The platform's tunable properties and stimuli-responsive release mechanisms offer versatility for various therapeutic applications.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

